IFF

AI Research

Food Ingredients unit sale launched → 2026 revenue guidance $10.50B-$10.80B

IFF launched a formal sale process for its Food Ingredients business alongside 2026 guidance for $10.50-$10.80B in sales and $2.05-$2.15B adjusted EBITDA. The company plans to reinvest proceeds into higher-margin Taste, Scent, and Health & Biosciences segments while prioritizing cash flow and balance sheet strength. IFF stock is up 3.9% YTD, and 20 analysts maintain a "Moderate Buy" with a $91.35 mean target representing 30.5% upside.